Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SOFIVA GENOMICS CoROCO:6615 +0.15%69 OCF Yield % is 2.06 as of Jul. 22, 2026, which is 48% below its 10-year median of 3.99. GuruFocus rates ROCO:6615 with a GF Score™ of 69/100 and a GF Value™ of NT$30.94 (Fairly Valued). The stock has 3 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, SOFIVA GENOMICS Co ranks better than 54.93% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for SOFIVA GENOMICS Co's OCF Yield % or its related term are showing as below:
ROCO:6615'
s OCF Yield % Range Over the Past 10 Years
Min: 0.19 Med: 3.99 Max: 9.15
Current: 2.06
During the past 13 years, the highest OCF Yield % of SOFIVA GENOMICS Co was 9.15%. The lowest was 0.19%. And the median was 3.99%.
ROCO:6615's OCF Yield % is ranked better than 54.93% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.07
vs ROCO:6615: 2.06
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
SOFIVA GENOMICS Co OCF Yield % Related Terms
SOFIVA GENOMICS Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for SOFIVA GENOMICS Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6615 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFIVA GENOMICS Co OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where SOFIVA GENOMICS Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOFIVA GENOMICS Co (ROCO:6615) has a OCF Yield % of 2.06 as of Jul. 22, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SOFIVA GENOMICS Co and its competitors. This is 48% below median its historical median of 3.99. Over the past decade, SOFIVA GENOMICS Co's OCF Yield % has ranged from 0.19 to 9.15. According to the industry distribution chart, SOFIVA GENOMICS Co ranks #96 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 45.1%.
Is SOFIVA GENOMICS Co's OCF Yield % too high?
SOFIVA GENOMICS Co's current OCF Yield % of 2.06 is 48% below median its 10-year median of 3.99. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 9.15. The Medical Diagnostics & Research industry median OCF Yield % is 1.07. SOFIVA GENOMICS Co's value of 2.06 is 92.5% above this industry median. Based on the distribution chart, SOFIVA GENOMICS Co ranks #96 out of 213 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, SOFIVA GENOMICS Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does SOFIVA GENOMICS Co's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, SOFIVA GENOMICS Co ranks #96 out of 213 companies for OCF Yield %. This puts SOFIVA GENOMICS Co in the upper half of its industry. The industry median OCF Yield % is 1.07. SOFIVA GENOMICS Co's value of 2.06 is 92.5% above this benchmark. Historically, SOFIVA GENOMICS Co's own OCF Yield % has ranged from 0.19 to 9.15 over the past decade. While the company's 10-year median is 3.99 vs. the industry median of 1.07, SOFIVA GENOMICS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.07, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOFIVA GENOMICS Co's current OCF Yield % of 2.06 is 92.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SOFIVA GENOMICS Co and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFIVA GENOMICS Co's current OCF Yield % is 2.06, which is 48% below median its own 10-year median of 3.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFIVA GENOMICS Co stock overvalued right now?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co (ROCO:6615) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.94, compared to a current price of NT$34.05 — trading 10.1% above its estimated fair value. The current OCF Yield % is 2.06, which is 48% below median its 10-year median of 3.99 and 92.5% above the Medical Diagnostics & Research industry median of 1.07. SOFIVA GENOMICS Co's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For SOFIVA GENOMICS Co (ROCO:6615), the current OCF Yield % is 2.06 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFIVA GENOMICS Co (ROCO:6615) Overvalued in 2026?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co stock appears to be overvalued.
The current stock price of NT$34.05 is trading 10.1% above its estimated GF Value™ of NT$30.94.
GuruFocus considers SOFIVA GENOMICS Co to be Fairly Valued.
Key valuation signals for ROCO:6615:
OCF Yield %: 2.06 (48% below median its 10-year median of 3.99)
GF Value™: NT$30.94 vs. price of NT$34.05 (10.1% above fair value)
Industry Position: 92.5% above the Medical Diagnostics & Research median (#96 of 213)
No single metric tells the full story. See the ROCO:6615 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.
69GF Score
Get the complete analysis for ROCO:6615
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6615 has been successfully added to your 
